Newly cleared AI software can detect and quantify breast arterial calcification on mammograms. The technology may support cardiovascular-risk conversations, but practices need clear reporting and referral pathways….
FDA has proposed moving digital breast tomosynthesis systems from Class III to Class II. Here is what the change could mean for manufacturers and mammography facilities—and what would remain unchanged….